Thomas Jake Andrew, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 508 Stocktrail Ave Ste D, Gillette, WY 82716 Phone: 307-688-8000 |
Cassidy R Drevlow, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1013 E Boxelder Rd Ste 100, Gillette, WY 82718 Phone: 307-682-4900 |
Andrew Nielsen, PT, DPT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 1103 E Boxelder Rd Ste U, Gillette, WY 82718 Phone: 307-686-8177 Fax: 307-686-9484 |
Dr. Stephenie Jo Means, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 222 S Gillette Avenue Suite 603, Gillette, WY 82716 Phone: 307-696-6070 Fax: 307-682-4996 |
North Platte Physical Therapy Services Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 4j Ct, Gillette, WY 82716 Phone: 307-686-2569 |
Lee Colleen Sowada, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 603 S Gillette Ave, Gillette, WY 82716 Phone: 307-682-2500 |
Shelby Kline, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1211 S Douglas Hwy Ste 120, Gillette, WY 82716 Phone: 307-670-8111 Fax: 307-670-8113 |
Gillette Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1013 East Boxelder, Gillette, WY 82718 Phone: 307-682-4900 Fax: 307-687-7243 |
Rehab Solutions Physical Therapist Medicare: Medicare Enrolled Practice Location: 1103 E Boxelder Rd, Suite U, Gillette, WY 82718 Phone: 307-686-8177 Fax: 307-686-9484 |
Dr. Aaron Charles Proefrock, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1103 E Boxelder Rd Ste U, Gillette, WY 82718 Phone: 307-686-8177 |
Jordan Soloai, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 508 Stocktrail Ave Ste D, Gillette, WY 82716 Phone: 307-688-8000 |
Hannah Lynn Christine Proefrock, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 902 E 3rd St, Gillette, WY 82716 Phone: 307-756-9200 Fax: 307-756-9203 |
Physical Therapy Of Wyoming Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1211 S Douglas Hwy Ste 120, Gillette, WY 82716 Phone: 307-670-8111 Fax: 307-670-8113 |
Braden Benson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1013 E Boxelder Rd, Gillette, WY 82718 Phone: 307-682-4900 |
Ragen Wilson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1211 S Douglas Hwy Ste 100, Gillette, WY 82716 Phone: 307-670-9191 Fax: 307-670-9193 |
Tiffany Nicole Nielsen, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1103 E Boxelder Rd Ste U, Gillette, WY 82718 Phone: 307-686-8177 Fax: 307-686-9484 |
Susette Ada Stiles-hofland, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 S 4j Ct, Gillette, WY 82716 Phone: 307-290-0572 Fax: 307-290-0572 |
Brittany K Johnson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 4j Ct, Gillette, WY 82716 Phone: 307-686-2569 Fax: 307-386-2615 |
Jerrica L Huber, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1103 E Boxelder Rd Ste U, Gillette, WY 82718 Phone: 307-686-8177 Fax: 307-686-9484 |
Mr. Daniel R Clouston, ORT,CHT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1013 E Boxelder Rd, Gillette, WY 82718 Phone: 307-682-4900 Fax: 307-687-7243 |
News Archive
The neuroscientist Dr David Vilchez and his team at CECAD, the University of Cologne's Cluster of Excellence for Aging Research, have made an important step towards understanding the mechanisms that cause the neurodegenerative disorder Huntington's disease.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Company's PI3K/Akt pathway inhibitor compound, perifosine (KRX-0401), for the treatment of relapsed/refractory multiple myeloma.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
Providing clues to deafness, researchers at Washington University School of Medicine in St. Louis have identified a gene that is required for proper development of the mouse inner ear.
› Verified 2 days ago